Torsten Haneke
Impact in
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
-
- CAR-T cell therapy research
Papers in
- Oncology 11
- CAR-T cell therapy research 10
- HER2/EGFR in Cancer Research 2
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Uwe Reusch (11 shared papers)Erich Rajkovic (6 shared papers)Ivica Fucek (6 shared papers)Joachim Koch (5 shared papers)Kristina Ellwanger (6 shared papers)Martin Treder (6 shared papers)Manfred Gessler (1 shared paper)Alexander Froschauer (1 shared paper)
- Journals
- Blood (4 papers)Cancer Research (4 papers)mAbs (2 papers)Journal of Clinical Oncology (1 paper)Gene (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Torsten Haneke
13 papers receiving 308 citations
Peers
Comparison fields: 5 of 44
- Immunology 127
- Oncology 127
- Hematology 28
- Radiology, Nuclear Medicine and Imaging 52
- Molecular Biology 138
Countries citing papers authored by Torsten Haneke
This map shows the geographic impact of Torsten Haneke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Haneke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Haneke more than expected).
Fields of papers citing papers by Torsten Haneke
This network shows the impact of papers produced by Torsten Haneke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Haneke. The network helps show where Torsten Haneke may publish in the future.
Co-authors
The 25 scholars most cited alongside Torsten Haneke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 82 | |
| 2 | 2021 | 54 | |
| 3 | 2019 | 52 | |
| 4 | 2008 | 39 | |
| 5 | 2006 | 37 | |
| 6 | 2018 | 26 | |
| 7 | 2010 | 10 | |
| 8 | 2017 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2017 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 1 | |
| 14 | 2019 | 0 | |
| 15 | 2021 | 0 |
About Torsten Haneke
Torsten Haneke is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Hematology, having authored 15 papers that have together received 322 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Cell Function and Interaction (5 papers), Acute Myeloid Leukemia Research (2 papers), Genetic factors in colorectal cancer (2 papers), HER2/EGFR in Cancer Research (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (127 citations), Oncology (127 citations), Hematology (28 citations), Radiology, Nuclear Medicine and Imaging (52 citations) and Molecular Biology (138 citations). Torsten Haneke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Uwe Reusch, Erich Rajkovic, Ivica Fucek, Joachim Koch, Kristina Ellwanger, Martin Treder, Manfred Gessler, Alexander Froschauer, Susanne Wingert and Christina Schultheis. Their work appears in journals such as Blood, Cancer Research, mAbs, Journal of Clinical Oncology and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.